Stephens Consulting, LLC Evolus, Inc. Transaction History
Stephens Consulting, LLC
- $422 Billion
- Q2 2025
A detailed history of Stephens Consulting, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 290 shares of EOLS stock, worth $2,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
290
Previous 320
9.38%
Holding current value
$2,763
Previous $3.85 Million
30.62%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EOLS
# of Institutions
186Shares Held
51.8MCall Options Held
142KPut Options Held
58.4K-
Tang Capital Management LLC San Diego, CA5MShares$47.6 Million3.9% of portfolio
-
Perceptive Advisors LLC New York, NY4.13MShares$39.4 Million2.08% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$38.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.65MShares$34.8 Million1.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$30.8 Million0.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $535M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...